Bibloc(BisoHEXAL 2.5 mg Film-coated Tablets)
Bisoprolol fumarate
Bibloc and BisoHEXAL 2.5 mg Film-coated Tablets are different trade names for the same drug.
Bibloc belongs to a group of medicines called beta-blockers. They protect the heart from excessive activity.
Bibloc is used to treat:
If you have any doubts, you should consult your doctor.
Before taking Bibloc, you should consult your doctor:
There is currently no therapeutic experience with the use of Bibloc in heart failure in the following patients:
Treatment of heart failure with Bibloc requires regular medical monitoring. This is absolutely necessary, especially at the beginning of treatment and after its completion.
Do not stop taking Bibloc suddenly without a compelling reason.
If any of the described warnings apply to you or have applied in the past, you should consult your doctor.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take. This includes medicines that are available without a prescription. Certain medicines should not be taken at the same time as Bibloc, and others may require changes, such as dose adjustments.
In any case, you should inform your doctor about taking or receiving the following medicines in addition to Bibloc:
Alcohol may enhance the dizziness and drowsiness caused by Bibloc. In such cases, you should avoid drinking alcohol.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor before taking this medicine. Bibloc may harm the pregnancy and/or the fetus. The risk of premature birth, miscarriage, low blood sugar in the child, and slowed heart rate increases. The medicine may also affect the development of the child. Therefore, Bibloc should not be taken during pregnancy.
It is not known whether bisoprolol passes into breast milk, so it is not recommended to take Bibloc while breastfeeding.
The medicine may cause fatigue, drowsiness, or dizziness. If you experience these symptoms, you should not drive or operate machinery. You should be aware that such symptoms may occur, especially at the beginning of treatment, when changing the medicine, or when consuming alcohol.
If you have been diagnosed with intolerance to some sugars, you should contact your doctor before taking the medicine.
This medicine contains less than 1 mmol (23 mg) of sodium per film-coated tablet, which means it is essentially "sodium-free".
This medicine should always be taken exactly as your doctor or pharmacist has told you. If you are not sure, you should contact your doctor or pharmacist.
Your doctor will tell you how many tablets to take. The medicine should be taken in the morning, before, during, or after breakfast. The tablet(s) should be swallowed with a small amount of water. The tablets should not be chewed or crushed.
Typically, the recommended dose is:
Before starting treatment with Bibloc, you are usually already taking an ACE inhibitor, diuretic, or digitalis glycoside (a heart medicine and antihypertensive).
The dose of Bibloc will be gradually increased until the optimal dose for you is reached:
1.25 mg once daily for 1 week. If this dose is well tolerated, it can be increased to:
2.5 mg once daily for the next week. If this dose is well tolerated, it can be increased to:
3.75 mg once daily for the next week. If this dose is well tolerated, it can be increased to:
5 mg once daily for 4 consecutive weeks. If this dose is well tolerated, it can be increased to:
7.5 mg once daily for 4 consecutive weeks. If this dose is well tolerated, it can be increased to:
10 mg once daily (maintenance dose).
The maximum dose is 10 mg once daily.
Your doctor will determine the optimal dose for you based on, among other things, side effects.
After the first dose of 1.25 mg, your doctor will check your blood pressure, heart rate, and heart function.
Liver or kidney function disorders
Your doctor will increase the dose of Bibloc with caution.
Elderly
Dose adjustment is usually not necessary.
If you feel that the effect of Bibloc is too strong or too weak, you should inform your doctor or pharmacist.
Place the tablet on a hard, flat surface, with the notch facing up.
Press your thumb on the center of the tablet. The tablet will break into two equal halves.
Duration of treatment
Bibloc is usually taken for a long time.
Due to the lack of studies on the effect of Bibloc in children and adolescents, its use is not recommended in this age group.
In case of accidental ingestion of a higher dose than recommended, you should immediately contact
your doctor or pharmacist. You should take the remaining tablets or this leaflet with you, so that the medical staff knows which medicine was taken. Symptoms of overdose may include dizziness, drowsiness, fatigue, shortness of breath, and/or wheezing. Slow heart rate, low blood pressure, inadequate heart contractions, and low blood sugar (which can cause hunger, excessive sweating, and palpitations) may also occur.
You should not take a double dose to make up for a missed dose. You should take your normal dose as soon as you remember, and the next day return to your normal dosing schedule.
You should not stop taking Bibloc suddenly. If you stop treatment abruptly, your condition may worsen. The dose of Bibloc should be gradually reduced over several weeks, as advised by your doctor.
If you have any further doubts about taking this medicine, you should consult your doctor or pharmacist.
Like all medicines, Bibloc can cause side effects, although not everybody gets them.
If a side effect is severe, occurs suddenly, or worsens rapidly, you should contact your doctor immediately to prevent serious reactions.
The most serious side effects are related to heart function:
If you experience dizziness, weakness, or difficulty breathing, you should contact your doctor as soon as possible.
If you experience severe hypersensitivity reactions, which can include swelling of the face, neck, tongue, lips, or throat, or difficulty breathing, you should contact your doctor immediately.
The following side effects are listed according to their frequency:
Frequent (may occur in less than 1 in 10 people):
Uncommon (may occur in less than 1 in 100 people):
Rare (may occur in less than 1 in 1000 people):
Very rare (may occur in less than 1 in 10,000 people):
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Translation of some information on the immediate packaging:
Ch.-B./verwendbar bis: siehe Prägung– batch number/expiry date: see imprint.
There are no special precautions for storage.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
White, round, film-coated tablets with a notch, marked with "BIS 2.5" on one side.
The tablets can be divided into equal doses.
The tablets are packaged in OPA/Aluminum/PVC/Aluminum blisters in a cardboard box.
The blisters contain 25 or 50 tablets.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
Hexal AG
Industriestraße 25
83607 Holzkirchen, Germany
Lek S.A., ul. Podlipie 16, Stryków 95-010, Poland
Salutas Pharma GmbH, Otto-von-Guericke-Allee 1, 39179 Barleben, Germany
Rowa Pharmaceuticals Limited, Newtown, Bantry, Co. Cork, Ireland
Lek Pharmaceuticals d.d, Verovskova ulica 57, 1526 Ljubljana, Slovenia
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in Germany, the country of export:71879.00.00
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.